Belite Bio, Inc

Rentabilidade por seis meses: +0.8638%
Rendimento de dividendos: 0%
Setor: Healthcare

59.55 $

0 $ 0%
46.04 $
83.66 $

paper.min_max_per_year

Cronograma de promoção Belite Bio, Inc

Parâmetros básicos

IPO date
2022-04-29
ISIN
US07782B1044
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Nota

Subestimação
Nome Significado Nota
P/S 0 0
P/BV 13.77 1
P/E 0 0
Eficiência
Nome Significado Nota
ROA -29.29 0
ROE -30.6 0
ROIC 0 0
Dividendos
Nome Significado Nota
Rendimento de dividendos 0 0
DSI 0 0
Crescimento médio dos dividendos 0 0
Obrigação
Nome Significado Nota
Debt/EBITDA -0.0172 10
Debt/Ratio 0.0035 10
Debt/Equity 0.0433 10
Impulso de crescimento
Nome Significado Nota
Receita, % 0 0
Ebitda, % 453.14 10
EPS, % 375.57 10

paper.price.prices

Preço Common.min. Common.max. Mudar paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 59.55 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 61.19 $ 0 $ 0 $ -2.68 % 0 % 0 %
common.calendar.number_days.30d 61 $ 0 $ 0 $ -2.38 % 0 % 0 %
common.calendar.number_days.90d 56.6 $ 59.55 $ 67.29 $ +5.21 % 0 % 0 %
common.calendar.number_days.180d 59.04 $ 53.8 $ 69.49 $ +0.8638 % 0 % 0 %
common.calendar.number_days.1y 48.87 $ 46.04 $ 83.66 $ +21.85 % 0 % 0 %
common.calendar.number_days.3y 25.1 $ 11.18 $ 83.66 $ +137.25 % 0 % 0 %
common.calendar.number_days.5y 8.87 $ 8.87 $ 83.66 $ +671.36 % 0 % 0 %
common.calendar.number_days.10y 8.87 $ 8.87 $ 83.66 $ +671.36 % 0 % 0 %
common.calendar.number_days.ytd 56.21 $ 53.04 $ 69.49 $ +5.94 % 0 % 0 %

Principais proprietários

Empresas semelhantes



Gestão da empresa

Supervisor Cargo Pagamento Ano de nascimento
Dr. Yu-Hsin Lin M.B.A., Ph.D. Chairman of the Board of Directors & CEO N/A 1979 (46 anos)
Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A. CFO & Director N/A 1985 (40 anos)
Dr. Nathan L. Mata Ph.D. Chief Scientific Officer N/A 1967 (58 anos)
Dr. Hendrik P.N. Scholl M.A., M.D., Ph.D. Chief Medical Officer & Member of Ophthalmology Clinical Advisory Board

Informações da empresa

Endereço: United States, San Diego. CA, 12750 High Bluff Drive - Abrir no google maps, Abrir mapas yandex
Site: https://belitebio.com

Sobre a empresa Belite Bio, Inc

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases (STGD1). Its lead product candidate is LBS-008 (Tinlarebant), an orally administered, once-a-day tablet for maintaining the health and integrity of retinal tissues in STGD1 and GA patients. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.